This item requires a subscription to Journal of Pharmacology and Experimental Therapeutics.
Cover
Full Text (PDF)
INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA:
  • Robbin M. Brodbeck,
  • Daniel N. Cortright,
  • Andrzej P. Kieltyka,
  • Jianying Yu,
  • Carolyn O. Baltazar,
  • Marianne E. Buck,
  • Robin Meade,
  • George D. Maynard,
  • Andrew Thurkauf,
  • Du-Shieng Chien,
  • Alan J. Hutchison,
  • and James E. Krause
Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist J Pharmacol Exp Ther December 2008 327:898-909; published ahead of print August 27, 2008, doi:10.1124/jpet.108.141572
To view this item, select one of the options below:

This Article

  1. Published online before print August 27, 2008, doi: 10.1124/jpet.108.141572 JPET December 2008 vol. 327 no. 3 898-909
  1. Show PDF in full window
  2. AbstractFree
  3. Full Text
  4. » Full Text (PDF)
  5. Data Supplement

Responses

  1. Submit a response
  2. No responses published

Current Issue

  1. November 2009, 331 (2)
  1. Current Issue
  1. Alert me to new issues of JPET